| Supplementary Protection Certificate (SPC) Summary | |||
| SPC No. | 2018/002 | ||
|---|---|---|---|
| Date of filing | 10/01/2018 | ||
| Notification of Application Published | 07/02/2018 | ||
| Status | Granted | ||
| Notification of Grant Published | 21/08/2019 | ||
| Date of Expiry of SPC | 18/07/2032 | ||
| Applicant |
CHIESI FARMACEUTICI S.p.A. Via Palermo, 26/A 43100 Parma ITALY |
||
| Patent Number | 2515855 | ||
| Title of Invention | Combination therapy for COPD | ||
| Date of Expiry of Patent | 21/12/2030 | ||
| Product Type | Medicinal Product | ||
| Product Identity | A combination of glycopyrronium bromide, formoterol or a salt thereof and beclometasone dipropionate. | ||
| Market Authorisation | Ireland | ||
| Authorisation No | EU/1/17/1208 | ||
| Authorisation Date | 17/07/2017 | ||
| Identity of Product Authorised | Trimbow - beclometasone / formoterol / glycopyrronium bromide | ||
| Address for Service |
TOMKINS & CO. 5 Dartmouth Road Dublin 6 IRELAND |
||
| Renewal Fees | |||
| 25/07/2019 | Supplementary Protection Certificate Number 2018/002, having an expiry date of 18/07/2032 granted on 25/07/2019. | ||